Two Directors at Regeneron Pharmaceuticals Inc sold after exercising options/sold 122,830 shares at between 974.303USD and 979.225USD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City on Wednesday, June 5, at 8:30 a.m. EDT. Those interested in listening to the live or recorded session can access it from the . The recording will be available for 90 days. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great scienc...
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024 Grace Sun, 16, receives $75,000 Top Award for a new kind of organic electrochemical transistor at the world’s largest pre-college science, technology, engineering and math (STEM) competition. TARRYTOWN, N.Y. and WASHINGTON, D.C., May 17, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Grace Sun, 16, of Lexington, Kentucky, won the $75,000 top award, the George D. Yancopoulos Inno...
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
Burlington Stores, Inc. Announces First Quarter Fiscal Year 2024 Earnings Release Date, Conference Call and Webcast BURLINGTON, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel at everyday low prices, will release its first quarter fiscal year 2024 results before the U.S. stock market opens on Thursday, May 30, 2024. The Company will also hold a conference call to discuss results at 8:30 a.m. (Eastern Time) that day. The U.S. toll free dial-in for the conference call is 1-800-715-9871 ...
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer Myriad’s Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1 SALT LAKE CITY, May 16, 2024 (GLOBE NEWSWIRE) -- . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced that JCO Precision Oncology has published a showing a clinical cell-cycle risk (CCR) score can accurately predict the benefit of adding androgen deprivation t...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced two Solutions Innovation Research Awards (SIRA) presented to Professors and . These separate awards recognize their outstanding contributions to advanced materials research. Electrocatalysis plays a pivotal role in advancing clean energy systems. Enhancing the efficiency of chemical reactions at electrode surfaces can accelerate the transition to sustainable energy sources. High-entropy nanoparticles—materials that incorporate many different types of atoms into one lattice—offer a fresh perspective in electrocatalysis. Their ...
CooperCompanies to Participate in the Jefferies Global Healthcare Conference SAN RAMON, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the Jefferies Global Healthcare Conference on Wednesday, June 6, 2024. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 1:30 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at . About CooperCompanies CooperComp...
A director at CRA International Inc sold 2,500 shares at 164.055USD and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
CooperCompanies to Participate in the William Blair Growth Stock Conference SAN RAMON, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the William Blair Growth Stock Conference on Wednesday, June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled at 11:00 AM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at . About CooperCompanies CooperCompanies (Nasdaq: COO) ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.